Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIV
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Inovio Pharmaceuticals
Related studies linked through entity extraction aliases.
Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers
- Status
- WITHDRAWN
- Phase
- PHASE1
dMAbs for Prevention of COVID-19
- Status
- COMPLETED
- Phase
- PHASE1
INO-4201 as Booster in Healthy VSV-ZEBOV Vaccinees
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
INO 5401 Vaccination in BRCA1/2 Mutation Carriers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana
- Status
- COMPLETED
- Phase
- PHASE1
Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations
- Status
- COMPLETED
- Phase
- PHASE1
A Study of INO-A002 in Healthy Dengue Virus-naive Adults
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection
- Status
- COMPLETED
- Phase
- PHASE1
Therapeutic Vaccination in Treated HIV Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions
- Status
- COMPLETED
- Phase
- PHASE2
INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2